First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $157.66 | 52-week high | $166.00 |
| Prev. close | $156.81 | 52-week low | $121.68 |
| Day low | $156.58 | Volume | 38,000 |
| Day high | $157.93 | Avg. volume | 32,663 |
| 50-day MA | $155.19 | Dividend yield | N/A |
| 200-day MA | $150.80 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.48B |
| Net Asset Value (NAV) | $156.95 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| EXAS | Exact Sciences Corporation | 4.24% |
| ACAD | ACADIA Pharmaceuticals Inc. | 4.06% |
| RARE | Ultragenyx Pharmaceutical Inc. | 3.97% |
| IONS | Ionis Pharmaceuticals Inc. | 3.95% |
| AGIO | Agios Pharmaceuticals Inc. | 3.84% |
| GRFS | Grifols S.A. (ADR) | 3.75% |
| BIIB | Biogen Inc. | 3.51% |
| EXEL | Exelixis Inc. | 3.47% |
| QGEN | QIAGEN N.V. | 3.46% |
| ALKS | Alkermes Plc | 3.39% |
FBT Price Returns
| 1-mo | 1.57% |
| 3-mo | 3.64% |
| 6-mo | 1.32% |
| 1-year | 18.39% |
| 3-year | -2.12% |
| 5-year | 12.75% |
| YTD | 2.29% |
| 2022 | -4.83% |
| 2021 | -2.26% |
| 2020 | 12.96% |
| 2019 | 19.74% |
| 2018 | -0.30% |